The present disclosure provides novel compositions and methods for treating an infection by Middle East respiratory syndrome coronavirus (MERS-CoV). In particular, the present disclosure provides methods that entail administering agents having an anchoring domain that anchors the compound to the surface of a target cell, and a sialidase domain that can act extracellularly to inhibit infection of a target cell by MERS:CoV.
